| abstract |
Provided are methods and compositions designed for the treatment or management of acute coronary syndromes, particularly unstable angina and acute myocardial infarction. Effectively comprising one or more therapeutic agents that specifically reduce or inhibit phagocytic activity, including but not limited to macrophages and monocytes, and / or eliminate or reduce the amount of phagocytic cells Administration of the correct amount of the formulation. The formulation is specifically targeted by phagocytic cells. The formulation is also administered to a subject currently suffering from or recently suffered from acute coronary syndromes such as unstable angina and acute myocardial infarction. [Selection] Figure 1 |